Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE

BACKGROUND: In the phase 2 PACIFIC-STROKE trial (Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following Acute Noncardioembolic Stroke), asundexian, an oral factor XIa inhibitor, did not increase the risk of hemorrhagic transformation (HT). In this secondary analysis, w...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	STROKE 2024-06, Vol.55 (6), p.1477-1488
Hauptverfasser:	Chen, Chih-Hao, Shoamanesh, Ashkan, Colorado, Pablo, Saad, Feryal, Lemmens, Robin, De Marchis, Gian Marco, Caso, Valeria, Xu, Lizhen, Heenan, Laura, Masjuan, Jaime, Christensen, Hanne, Connolly, Stuart J, Khatri, Pooja, Mundl, Hardi, Hart, Robert G, Smith, Eric E
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!